- Home
- The group
- Life pillar
- SPYONAX MEDSTEM
Life pillar
SPYONAX MEDSTEM
Stem cell and medicine research, development and sales.
RoadmapPhase 5
Overview
SPYONAX MEDSTEM
SPYONAX MEDSTEM will research stem cells and regenerative medicine alongside wider medicine R&D: drug discovery, diagnostics and medical devices. It will sell medicines and products only once each is approved.
- Pillar
- Life
- Status
- Roadmap
- Roadmap
- Phase 5
- Research partner
- SPYONAX BIO LAB, SPYONAX AI LAB
Businesses
6 businesses
- SPYONAX STEM CELLStem cell research and regenerative medicine
- SPYONAX PHARMAMedicines, from discovery to approval
- SPYONAX BIOTECHBiotechnology products
- SPYONAX DIAGNOSTICSDiagnostic services and AI diagnostics
- SPYONAX MEDTECHMedical devices
- SPYONAX HEALTHCAREHospitals and care delivery
R&D and sales
Research, development and sales
Research & development
- Stem cell biology
- Regenerative medicine
- Drug discovery and development
- Diagnostics and medical devices
Sales
- Medicines, once approved
- Diagnostic services and kits
- Medical devices
- Biotechnology products
How it starts
Data first, then scale
01
First step
AI diagnostics software and stem cell research, each with the approvals it needs.
02
Grows when
Medical and regulatory leadership in place and approvals mapped.
Connected to
Works with
No treatments offered. SPYONAX MEDSTEM does not offer any stem cell or other treatment. Any therapy will be offered only after clinical trials and regulatory approval.
On the roadmap. SPYONAX MEDSTEM is part of our long-term plan and is not operating today.
Next sectorSPYONAX INVESTMENT